Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 331 AL 345

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

Albertyn CP, Guu TW, Chu P, Creese B, Young A, Velayudhan L, Bhattacharyya S, Jafari H, Kaur S, Kandangwa P, Carter B, Aarsland D.

Age Ageing. 2025 May 31;54(6):afaf149. doi: 10.1093/ageing/afaf149.

Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta-Analysis of ASL-MRI and FDG-PET

Radmard M, Gad M, Sheikhy A, Dagher R, Yedavalli V, Luna LP.

J Neuroimaging. 2025 Sep-Oct;35(5):e70080. doi: 10.1111/jon.70080.

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial

Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada Rovira M, Doraiswamy PM, Liang E, Flint S, Kesslak JP, McLaine R, Albayrak A, Schaefer J, Yu J, Tolar L, Dickson S, Hey JA, Tolar M.

Drugs. 2025 Nov;85(11):1455-1472. doi: 10.1007/s40265-025-02250-5. Epub 2025 Sep 28.

Objective Criteria for Subtle Cognitive Decline in Aging and Preclinical Alzheimer Disease: A Systematic Review

Thomas KR, Edmonds EC.

Neurology. 2025 May 13;104(9):e213536. doi: 10.1212/WNL.0000000000213536. Epub 2025 Apr 8.

Intervention Effects of the Holistic Physio-Cognitive Rehabilitation for Alzheimer Disease and Mild Cognitive Impairment

Osawa A, Maeshima S, Kamiya M, Ueda I, Itoh N, Kondo I, Arai H.

Ann Geriatr Med Res. 2025 Jun;29(2):207-212. doi: 10.4235/agmr.24.0158. Epub 2025 Feb 25.

Effects of intermittent theta-burst stimulation on cognition and glymphatic system activity in mild cognitive impairment and very mild Alzheimer's disease: a randomized controlled trial

Yang CC, Huang KY, Hsu JL, Hu CJ, Lu YH, Kuan YC.

J Neuroeng Rehabil. 2025 Sep 26;22(1):195. doi: 10.1186/s12984-025-01738-1.

Investigation of patterns and associations of neuroinflammation in cognitive impairment

Gan R, Xie H, Zhao Z, Wu X, Wang R, Wu B, Chen Q, Jia Z.

Cereb Cortex. 2025 Feb 5;35(2):bhaf013. doi: 10.1093/cercor/bhaf013.

Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's disease

Devanarayan V, Donohue MC, Sperling RA, Johnson KA, Ye Y, Charil A, Doherty T, Tian L, Raman R, Aisen PS, Kramer LD, Irizarry MC, Dhadda S.

Alzheimers Dement. 2025 Sep;21(9):e70702. doi: 10.1002/alz.70702.

Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study

Windon CC, Gatsonis C, Carrillo MC, Romanoff J, Hanna L, Glavin E, Gareen I, Gutman R, Hillner BE, March A, O'Bryant S, Rissman RA, Siegel BA, Smith K, Whitmer RA, Weber CJ, Wilkins CH, Dilworth-Anderson P, Rabinovici GD.

Alzheimers Dement. 2025 Jul;21(7):e70504. doi: 10.1002/alz.70504.

Eligibility for donanemab trial in a population-based study of cognitive aging

Jones KE, Aakre JA, Castillo AM, Ramanan VK, Kremers WK, Jack CR Jr, Vemuri P, Schwarz CG, Lowe VJ, Knopman DS, Petersen RC, Graff-Radford J, Vassilaki M.

J Prev Alzheimers Dis. 2025 Apr;12(4):100088. doi: 10.1016/j.tjpad.2025.100088. Epub 2025 Feb 17.

Gamma oscillation modulation for cognitive impairment: A systematic review

Bartolini E, Di Crosta A, La Malva P, Marin A, Ceccato I, Prete G, Mammarella N, Di Domenico A, Palumbo R.

J Alzheimers Dis. 2025 May;105(2):331-350. doi: 10.1177/13872877251328698. Epub 2025 Mar 28.

Brain patterns and risk factors in the FINGER RCT multimodal lifestyle intervention

Lorenzon G, Marseglia A, Mohanty R, Lehtisalo J, Poulakis K, Ngandu T, Solomon A, Kivipelto M, Westman E.

J Prev Alzheimers Dis. 2025 Dec;12(10):100390. doi: 10.1016/j.tjpad.2025.100390. Epub 2025 Sep 24.

The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jan;21(1):e14335. doi: 10.1002/alz.14335. Epub 2024 Dec 23.

Efficacy of music therapy as a non-pharmacological measure to support alzheimer's disease patients: a systematic review

Wang J, Liu C, Dai Y, Mei C, Wang G, Wang Y, Huang T, Zhan J, Cheng J.

BMC Geriatr. 2025 Jul 8;25(1):508. doi: 10.1186/s12877-025-06073-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias